Deploying a rapid point-of-care polymerase chain reaction test for SARS-CoV-2 in a clinical research unit to ensure healthy volunteer safety

The entire world was severely affected by the outbreak of the SARS-CoV-2 virus. Early phase clinical research was no exception and clinical healthy volunteer trials were halted across the globe. To enable continuation of development of new drugs, we developed a testing strategy for nonsymptomatic tr...

Full description

Bibliographic Details
Main Authors:	Brouwer, J.L (Author), Hays, A. (Author), Neat, J. (Author), Trigt, R.V (Author), Westerhof, H. (Author)
Format:	Article
Language:	English
Published:	Future Medicine Ltd. 2021
Subjects:	Article asymptomatic carrier clinical article clinical effectiveness clinical research controlled study coronavirus disease 2019 COVID-19 CRU diagnosis disease transmission epidemic gold standard Healthy Volunteers human Humans hygiene infection risk isolation and purification nonhuman normal human organization and management pandemic patient safety Phase I clinical trials point of care system point of care testing point-of-care PCR Point-of-Care Systems polymerase chain reaction Polymerase Chain Reaction procedures SARS-CoV-2 SARS-CoV-2 testing Severe acute respiratory syndrome coronavirus 2 social distancing social participation virology
Online Access:	View Fulltext in Publisher

Internet

View Fulltext in Publisher

Deploying a rapid point-of-care polymerase chain reaction test for SARS-CoV-2 in a clinical research unit to ensure healthy volunteer safety

Internet

Similar Items